Encephalomyelitis: Difference between revisions

Content deleted Content added
Reverting edit(s) by 2409:4055:4E9D:E7E:0:0:1BC8:620B (talk) to rev. 1026126147 by BattyBot: non-constructive (RW 16.1)
No edit summary
Tags: Reverted Visual edit
Line 23:
'''Encephalomyelitis''' is [[inflammation]] of the [[brain]] and [[spinal cord]]. Various types of encephalomyelitis include:
 
* ''[[Acute disseminated encephalomyelitis]]'' or ''postinfectious encephalomyelitis'', a [[demyelinating disease]] of the brain and spinal cord, possibly triggered by [[virus|viral]] infection.<ref>{{RareDiseases|8639|Acute disseminated encephalomyelitis}}</ref><ref>{{NINDS|acute_encephalomyelitis|Acute Disseminated Encephalomyelitis Information Page}}</ref>. Emerging evidences shows [[Acute disseminated encephalomyelitis|disseminated encephalomyelitis]] association with [[COVID-19]]<ref>{{Cite journal|last=Manikanta|first=Dr Achuta Kesava|last2=Pradeep|first2=Dr Ganipineni Vijay Durga|last3=Pydi|first3=Dr Reshma|last4=Chanumolu|first4=Dr Aditya Renu|last5=Joy|first5=Dr Levis Abin|last6=Kancherla|first6=Dr Neeraj|date=2021-06-14|title=Acute Disseminated Encephalomyelitis in COVID 19- Systematic Review|url=https://www.annalsofrscb.ro/index.php/journal/article/view/7656|journal=Annals of the Romanian Society for Cell Biology|language=en|volume=25|issue=6|pages=11443–11450}}</ref>
* ''Encephalomyelitis disseminata'', a synonym for [[multiple sclerosis]].
* ''[[AntiMOG associated encephalomyelitis]]'', one of the underlying conditions for the phenotype [[neuromyelitis optica]]<ref>Pröbstel AK et al. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. J Neuroinflammation. 2015 Mar 8;12(1):46.</ref><ref>Melania Spadaro et al. Histopathology and clinical course of MOG-antibody-associated encephalomyelitis. Annals of Clinical and Translational Neurology Volume 2, Issue 3, pages 295–301, March 2015 {{DOI|10.1002/acn3.164}}</ref> and in general all the spectrum of [[MOG autoantibody-associated demyelinating diseases]].<ref>Reindl M, Di Pauli F, Rostásy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol. 2013 Aug;9(8):455-61. {{doi|10.1038/nrneurol.2013.118}}. Epub 2013 Jun 25. {{PMID|23797245}}</ref>